Variations in flow, duration, and concentration do not change the final lung concentration of melphalan after isolated lung perfusion in rats

Eur Surg Res. 2003 Jan-Feb;35(1):50-3. doi: 10.1159/000067038.

Abstract

Objective: The influences of flow, perfusion time, and concentration on melphalan (MN) lung levels in a rat model of isolated lung perfusion (ILuP) were studied.

Methods: ILuP was performed in WAG/Rij rats by using a single-pass system with 0.5, 0.05, 0.01, and 0.005 mg of MN. Subsequently ILuP with 0.05 mg MN was performed during 30 min with a flow rate of 0.5 ml/min, during 60 min with a flow rate of 0.5 ml/min, and during 30 min with a flow rate of 1.0 ml/min.

Results: The lung MN levels of 0.05 mg were significantly lower as compared with 0.5 mg (p = 0.02). In the second experiment, no significant differences were seen in lung levels of MN between the different groups.

Conclusion: The final lung MN levels were only determined by the absolute amount administered.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antineoplastic Agents, Alkylating / administration & dosage*
  • Antineoplastic Agents, Alkylating / pharmacokinetics*
  • Dose-Response Relationship, Drug
  • In Vitro Techniques
  • Lung / metabolism*
  • Male
  • Melphalan / administration & dosage*
  • Melphalan / pharmacokinetics*
  • Osmolar Concentration
  • Perfusion*
  • Pulmonary Circulation*
  • Rats
  • Rats, Inbred Strains
  • Time Factors

Substances

  • Antineoplastic Agents, Alkylating
  • Melphalan